Concept information
Preferred term
Emepronium
Type
-
mesh:Descriptor
Definition
- A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.
Broader concept
Entry terms
- 04QQ8SWA4U
- 27892-33-7 (Emepronium)
- 3614-30-0 (bromide)
- Benzenepropanaminium, N-ethyl-N,N,alpha-trimethyl-gamma-phenyl-
- WZM699L2TL
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
04QQ8SWA4U
-
27892-33-7 (Emepronium)
-
3614-30-0 (bromide)
-
Benzenepropanaminium, N-ethyl-N,N,alpha-trimethyl-gamma-phenyl-
-
Éthyl-diméthyl-(1-méthyl-3,3-diphénylpropyl)ammonium
-
WZM699L2TL
URI
http://data.loterre.fr/ark:/67375/JVR-XGPTDCNF-M
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}